The scrutiny follows a critical report from Jehoshaphat Research, which disclosed a short position in the Canadian company. The research firm challenged Gildan’s reported revenue growth, arguing that the manufacturer’s underlying performance has been negative for years. Investors who purchased securities during the period in question may now be eligible for compensation through a pending class action lawsuit.

Rosen Law Firm is currently vetting shareholders to join the prospective litigation. Interested parties are encouraged to contact Phillip Kim to discuss potential recovery options, which operate on a contingency fee basis. While the firm highlights its history of securities litigation—including top rankings by ISS Securities Class Action Services—the legal team notes that prior settlements do not guarantee specific future outcomes.